BC99probioticspowderfeatureshighviability,excellentproductstability,andpleasantflavor.Itissuitableforvariousdosageformsincludingcapsules,tablets,andgranules,powder,anddemonstratesgoodstabilityinapplicationssuchascoffee,tea,mealreplacementpowders,andoatflakes.·Capsuleshellfillingtopreservethebioavail

AbstractThisstudyexploresthepropertiesandapplicationsofLactobacillusacidophilusLA18.IsolatedandpreservedunderthecodeCCTCCNO:M2022572,LA18demonstratessignificantpotentialinregulatinggutmicrobiota,modulatingimmuneresponses,andproducingshort-chainfattyacids(SCFAs).Thisstraineffectivelyinhibitspathogeni

AbstractTheinventionpertainstoaprobioticagentdesignedtomodulatetheguthormoneGLP-1levels,encompassingtheLacticaseibacillusrhamnosusLRa05strain(CGMCCNo.1.12734)anditsapplicationinobesitytreatment.TheLRa05strainsignificantlyenhancesGLP-1expressioninintestinalendocrinecells,reducingbodyweightandserumALT

AbstractThisstudyexploresthepotentialofLacticaseibacillusrhamnosusLRa05asanovelprobiotictreatmentforCandidalvaginitis.Isolatedfromfecalsamples,LRa05demonstratessuperiorantagonisticactivityagainstCandidaalbicans,surpassingcommerciallyavailablestrainsLGG,RC-14,andGR-1.Throughinvitroandinvivoexperiment

AbstractChronickidneydisease(CKD)isasignificanthealthconcerncharacterizedbytheaccumulationofuremictoxinsintheblood,whicharedifficulttoremoveviadialysis.Thisstudypresentsanovelprobioticcomposition,comprisingLacticaseibacillusrhamnosusLRa66andBifidobacteriumbifidumBBi32,designedtoregulateserumuremicto

Abstract:Thisstudyintroducesanovelprobioticagentwithsignificantanti-allergicproperties.Theagentcomprisestwostrains:Bifidobacteriumanimalissubsp.lactisBLa36andLacticaseibacilluscaseiLC89.Thesynergisticinteractionbetweenthesestrainsenhancestheirefficacyinalleviatingallergicreactions,providinganewstrat